- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pharyngocutaneous fistula: a common complication following laryngectomy: JAMA
Pharyngocutaneous fistula (PCF) results in an inflammatory reaction, but its association with the rate of locoregional and distant control, disease-free survival, and overall survival in laryngeal cancer remains uncertain.
A recent multicenter retrospective cohort study conducted by a team of researchers from the Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada found that development of pharyngocutaneous fistula after salvage laryngectomy is associated with an increased risk for the development of distant metastases.
The study is published in the JAMA Otolaryngology- Head & Neck Surgery.
The objective of the study was to determine if pharyngocutaneous fistula after salvage laryngectomy is associated with locoregional and distant control, disease-free survival, and/or overall survival.
A total of 550 patients who underwent salvage laryngectomy for recurrent laryngeal cancer were included in the study. The median follow-up time was 5.7 years (range, 0-18 years).
The results revealed that all the 550 patients (mean [SD] age, 64 [10.4] years; men, 465 [85%]) met inclusion criteria. Out of the entire sample, pharyngocutaneous fistula occurred in 127 patients (23%).
The difference in locoregional control between the group of patients with pharyngocutaneous fistula (75%) and the non– pharyngocutaneous fistula (72%) group was 3% (95% CI, −6% to 12%).
The difference in overall survival between the group with pharyngocutaneous fistula (44%) and the non– pharyngocutaneous fistula group (52%) was 8% (95% CI, −2% to 20%). The difference in disease-free survival between pharyngocutaneous fistula and non– pharyngocutaneous fistula groups was 6% (95% CI, −4% to 16%).
Furthermore, in the multivariable model, patients with pharyngocutaneous fistula were at a 2-fold higher rate of distant metastases (hazard ratio, 2.00; 95% CI, 1.22 to 3.27). Distant control was reduced in those with pharyngocutaneous fistula, a 13% (95% CI, 3% to 21%) difference in 5-year distant control.
As a result, the authors concluded that development of pharyngocutaneous fistula after salvage laryngectomy is associated with an increased risk for the development of distant metastases.
doi:10.1001/jamaoto.2021.1545
BDS, MDS( Pedodontics and Preventive Dentistry)
Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751